Ildoo Chung | Pharmacology | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Ildoo Chung | Pharmacology | Best Researcher Award

Ā Professor, Pusan National University South Korea

Ildoo Chung is a distinguished professor in the Department of Polymer Science and Engineering at Pusan National University, Korea. With a career spanning over two decades, he specializes in polymer chemistry, functional materials, and advanced biomedical engineering applications. Dr. Chung has held prominent academic and administrative positions, including department head and associate dean. He actively contributes to global research through editorial roles, conference leadership, and professional society memberships. Renowned for his dedication to education and innovation, Dr. Chung’s work bridges academia and industry, advancing polymer science worldwide.

Publication Profile

Scopus

Orcid

google scholar

šŸŽ“ Education

Ph.D. in Polymer Science & Engineering, Pusan National University, Korea (2000.08). M.S. in Polymer Science & Engineering, Pusan National University, Korea (1997.02). B.S. in Polymer Science & Engineering, Pusan National University, Korea (1995.02)

šŸ’¼ Experience

Professor, Pusan National University, Korea (2014ā€“present). Associate Dean, College of Engineering, Pusan National University (2018ā€“2020). Department Head, Polymer Science & Engineering, Pusan National University (2013ā€“2017). Visiting Associate Professor, University of Tennessee, USA (2012ā€“2013). Assistant/Associate Professor, Pusan National University (2005ā€“2014). Postdoctoral Fellow, University of Alabama at Birmingham, USA (2000ā€“2002)

šŸ† Awards & Honors

Member, Board of Directors, The Polymer Society of Korea. Editorial roles in Journal of Adhesion and Interface, IJMSE, and others. Numerous conference chair and committee memberships globally. Reviewer for high-impact journals like Macromolecular Research and Dental Materials. Recipient of national and international recognition for polymer research

šŸ”¬ Research Focus

Development of functional polymers for drug delivery and biomedical applications. Advanced polymer composites and their industrial applications. Interface engineering in polymer systems for sustainability. Nanostructured materials and their multifunctional properties. Polymer chemistry for healthcare innovations

Conclusion

Professor Ildoo Chungā€™s academic and professional journey reflects a commitment to advancing knowledge in polymer science and materials engineering. His leadership, research, and editorial work have significantly impacted the field, making him a deserving candidate for the Best Researcher Award. With continued efforts in interdisciplinary collaboration and practical applications, he has the potential to further elevate his influence and contributions to global scientific advancements.

Publication Top Notes

  • Title: L-Threonine-Derived Biodegradable Polyurethane Nanoparticles for Sustained Carboplatin Release
    Year: 2024
    Authors: Seoeun Oh, Soo-Yong Park, Hyung Il Seo, Ildoo Chung
    Citation: DOI: 10.3390/pharmaceutics17010028

 

  • Title: Derivatization of Hyaluronan to Target Neuroblastoma and Neuroglioma Expressing CD44
    Year: 2024
    Authors: Vo Van Giau, Giau Van Vo, Van-Giau Vo, Ildoo Chung, Chang-Sik Ha, Seong An, Yang H. Yun
    Citation: DOI: 10.3390/pharmaceutics16060836

 

  • Title: Depolymerized Chitosan-g-[Poly(MMA-co-HEMA-cl-EGDMA)] Based Nanogels for Controlled Local Release of Bupivacaine
    Year: 2023
    Authors: Sivagangi Reddy Nagella, Soojeong Choi, Soo-Yong Park, Chang-Sik Ha, Youngmi Jung, Ramesh Kumar Chitumalla, Joonkyung, Ji-Young Yoon, Ildoo Chung
    Citation: DOI: 10.3390/ijms242216470

 

  • Title: Effects of Recycled Polymer on Melt Viscosity and Crystallization Temperature of Polyester Elastomer Blends
    Year: 2023
    Authors: Ji-Eun Lee, Jin-Woo Lee, Jae-Wang Ko, Kyung-Il Jo, Hyun-Ju Park, Ildoo Chung
    Citation: DOI: 10.3390/ma16176067

 

  • Title: Carboxymethyl cellulose/montmorillonite bionanocomposite films incorporated with polyhedral oligomeric silsesquioxane
    Year: 2022
    Authors: Jin H., Yan Y.-Z., Lee C.S., Lee J.-H., Chung I., Ha C.-S.
    Citation: DOI: 10.1080/09276440.2022.2151262

 

  • Title: Effect of the Surface Modification of Silica Nanoparticles on the Viscosity and Mechanical Properties of Silica/Epoxy Nanocomposites
    Year: 2022
    Authors: Kim T., Kwon S.-H., Kim H.J., Lim C.-S., Chung I., Lee W.-K., Seo B.
    Citation: DOI: 10.1080/09276440.2022.2094572

 

  • Title: Polydopamine/Polypyrrole Modified Graphite Felt Enhances Biocompatibility for Electroactive Bacteria and Power Density of Microbial Fuel Cell
    Year: 2022
    Authors: Kim M., Li S., Kong D.S., Song Y.E., Park S.-Y., Kim H.-I., Jae J., Chung I., Kim J.R.
    Citation: EID: 2-s2.0-85133636105

 

  • Title: Polyol and Polyurethane Containing Bisphenol-Z: Synthesis and Application for Toughening Epoxy
    Year: 2022
    Authors: Lee D.Y., Kim H.J., Kim H.-G., Lim C.-S., Chung I., Seo B.
    Citation: DOI: 10.1002/app.53013

 

  • Title: ROS- and pH-Responsive Polydopamine Functionalized Tiā‚ƒCā‚‚Tā‚“ MXene-Based Nanoparticles as Drug Delivery Nanocarriers with High Antibacterial Activity
    Year: 2022
    Authors: Wei-Jin Zhang, Shuwei Li, Veena Vijayan, Lee Jun Seok, Sung Soo Park, Xiuguo Cui, Ildoo Chung, Jaejun Lee, Suk-kyun Ahn, Jung Rae Kim, et al.
    Citation: DOI: 10.3390/nano12244392

 

  • Title: Dual (pH- and ROS-) Responsive Antibacterial MXene-Based Nanocarrier for Drug Delivery
    Year: 2022
    Authors: Wei-Jin Zhang, Shuwei Li, Yong-Zhu Yan, Sung Soo Park, Anandhu Mohan, Ildoo Chung, Suk-kyun Ahn, Jung Rae Kim, Chang-Sik Ha
    Citation: DOI: 10.3390/ijms232314925

 

 

Daniela Malengo | Pharmacology | Women Researcher Award

Posted on by ScienceFather

Dr. Daniela Malengo | Pharmacology | Women Researcher Award

Dr at Istituto Europeo di Oncologia, Italy

Daniela Malengo, an Italian pharmacist, is currently the Vice Director of the Hospital Pharmacy Division at Istituto Europeo di Oncologia, Milan. With a career spanning over 15 years, Daniela specializes in oncology drug management, hospital pharmacy administration, and medical device protocols. She is passionate about optimizing pharmaceutical practices and contributing to oncology care. Throughout her career, she has been dedicated to ensuring the safe and effective use of drugs in oncological treatments and has supported numerous research projects. Her leadership skills also extend to teaching pharmacy students through internships and projects.

Profile

Scopus

šŸŽ“ EducationĀ 

Management of CAR-T Patients, LIUC Business School (Dec 2023ā€“Mar 2024). Hospital Pharmacy Management, UniversitĆ  Bocconi, Milan (Sept 2019ā€“Dec 2020). Specialization in Applied Pharmacology, University of Pavia (2005ā€“2009). Degree in Pharmacy, University of Pavia (2000ā€“2005). State Exam for Pharmacist License, University of Pavia (Novā€“Dec 2005). Scientific High School Diploma, Liceo Scientifico N. Copernico, Pavia (1995ā€“2000)

šŸ’¼ Experience

Vice Director of Hospital Pharmacy Division, Istituto Europeo di Oncologia, Milan (July 2023ā€“Present): Managing narcotic drug dispensation and overseeing oncological therapy. Assistant Pharmacist, Istituto Europeo di Oncologia, Milan (Mar 2011ā€“July 2023): Managed medical devices and chemotherapy prescriptions. Pharmacist ā€“ Research Fellow, Istituto Europeo di Oncologia, Milan (May 2006ā€“Feb 2011): Supervised experimental drugs and contributed to research on oncological drug appropriateness. Intern (2004ā€“2005): Worked at Farmacia Dott. A. Lodola, Siziano, dispensing medications to the public.

šŸ† Awards & Honors

Numerous presentations at national congresses, including SIFO Congress (2009ā€“2010). Recognized for contributions to hospital pharmacy management and cost analysis of oncological treatments. Leadership roles in pharmacy student internships and research programs. Awarded for excellence in promoting safe oncological drug usage.

šŸ”¬ Research Focus

Oncology Pharmacology: Focuses on managing oncological drug appropriateness, chemotherapy prescriptions, and medical device protocols. Pharmacy Management: Expertise in hospital pharmacy operations, including drug dispensation, quality control, and patient safety. Experimental Pharmacology: Managed experimental drugs and contributed to clinical research in oncological treatments. Cost Analysis: Focus on managing hospital pharmacy expenses and evaluating drug cost-effectiveness.

Conclusion

Daniela Malengo’s career exemplifies dedication to hospital pharmacy, oncological drug management, and the advancement of healthcare systems through her research and leadership roles. Her consistent contributions to improving patient outcomes in oncology, coupled with her academic excellence, make her a strong candidate for the Women Researcher Award. With her continued focus on improving the quality of healthcare services and mentoring future professionals, Danielaā€™s future contributions are poised to have a lasting impact in both the pharmacy and healthcare sectors.

šŸ“šPublicationsĀ 

  • The Prolonged Clinical Benefit with Metronomic Chemotherapy (VEX Regimen) in Metastatic Breast Cancer Patients
    • Authors: Montagna, E., Pagan, E., Cancello, G., Viale, G., Colleoni, M.
    • Journal: Anti-Cancer Drugs
    • Volume: 33
    • Issue: 1
    • Pages: E628ā€“E634
    • Year: 2022
    • Citations: 6

 

  • Management of Breast Cancer Patients During the Peak of the COVID-19 Pandemic
    • Authors: Montagna, E., Bellerba, F., Sangalli, C., Colleoni, M., Veronesi, P.
    • Journal: European Journal of Surgical Oncology
    • Volume: 47
    • Issue: 10
    • Pages: 2694ā€“2695
    • Year: 2021
    • Citations: 2

 

Srijan Acharya | Molecular Pharmacology | Excellence in Research

Posted on by ScienceFather

Dr. Srijan Acharya | Molecular Pharmacology | Excellence in Research

Dr at St. Jude Children’s Research Hospital, United States

Srijan Acharya is a dedicated scientist with expertise in molecular pharmacology and cancer genomics. He is currently a Post-Doctoral Research Fellow at St. Jude Childrenā€™s Research Hospital, focusing on childhood cancer research. With 32 published scientific articles and a total citation count of over 385, his work has contributed significantly to biomarker discovery, receptor pharmacology, and immuno-oncology. His research aims to address therapeutic resistance in pediatric malignancies through small molecule screening. Srijan is fluent in English, Bangla, and Hindi, with basic knowledge of Korean.

Profile

Scholar

šŸŽ“ Education

PhD in Molecular Pharmacology from Chonnam National University, South Korea (2020). M.Sc. in Biotechnology from North South University, Bangladesh (2015). BPHRM in Pharmacy from East West University, Bangladesh (2012). His academic journey has provided a strong foundation in receptor pharmacology and molecular biology, guiding his transition into cancer research.

šŸ’¼ Experience

Post-Doctoral Research Fellow, Pharmacy Department, St. Jude Childrenā€™s Research Hospital, USA (2023-Present). Post-Doctoral Research Fellow, Pathology Department, Mitchell Cancer Institute, USA (2020-2023). Executive Officer, Research and Development, Square Pharmaceutical PLC, Bangladesh (2012-2013). His experience spans academia and industry, with a focus on cancer research, receptor signaling, and small molecule screening.

šŸ† Awards and Honors

Inducted into Sigma Xi, The Scientific Research Honor Society (2023). Recognized in Whoā€™s Who in America by Marquis (2023). Young Investigator Award at AACR conference by AAISCR (2022). Best Presenter Award from China Pharmaceutical University (2021). Global Scholarship from Chonnam National University, Korea (2015). These accolades reflect his significant contributions to molecular pharmacology and cancer research.

šŸ”¬ Research Focus

Srijanā€™s research primarily investigates the role of molecular signaling in cancer, focusing on the interaction of nicotine receptors with GPCRs and their impact on cancer progression. At St. Jude, his work focuses on childhood cancers, particularly Ewing sarcoma and rhabdomyosarcoma. He uses small molecule screening to discover potential therapeutic agents and aims to overcome therapeutic resistance in pediatric cancers.

Conclusion

Srijan Acharya is a highly accomplished and promising researcher whose contributions to cancer pharmacology and molecular biology are noteworthy. His interdisciplinary research approach, combined with his dedication to advancing pediatric oncology, positions him as a leader in the field. With continued mentorship and broader collaborative efforts, Acharya is well poised for even greater achievements, further solidifying his place as an influential scientist in the biomedical community.

šŸ“šPublicationsĀ 

  • Title: Unveiling the intracellular dynamics of Ī±4Ī²2 nAChR-mediated ERK activation through the interplay of arrestin, GĪ²Ī³, and PKCĪ²II
    Year: 2024
    Authors: Dooti K, Acharya S, Wang S, Kim K.M.

 

  • Title: Biphasic transcriptional and posttranscriptional regulation of MYB by androgen signaling mediates its growth control in prostate cancer
    Year: 2023
    Authors: Acharya S, Anand S, Khan MA, Zubair H, Srivastava SK, Singh S, Singh AP

 

  • Title: MYB exhibits racially disparate expression, clinicopathologic association, and predictive potential for biochemical recurrence in prostate cancer
    Year: 2023
    Authors: Md Khan, S Acharya, S Anand, F Sameeta, P Pramanik, C Keel, S Singh, James E Carter, S Dasgupta, A Singh

 

  • Title: Comparative study of the molecular mechanisms underlying the G protein and Ī²-arrestin-dependent pathways that lead to ERKs activation upon stimulation by dopamine D2 receptor
    Year: 2023
    Authors: Liu H, Acharya S, Sudan SK, Hu L, Wu C, Cao Y, Li H, Zhang X

 

  • Title: Frequent loss of cacna1c, a calcium voltage-gated channel subunit is associated with lung adenocarcinoma progression and poor prognosis
    Year: 2023
    Authors: Dasgupta, S., Acharya, S., Khan, M. A., Pramanik, P., Marbut, S. M., Yunus, F., Galeas, J. N., Singh, S., Singh, A. P., and Dasgupta, S.

 

  • Title: Nicotine causes alternative polarization of macrophages via Src-mediated STAT3 activation: Potential pathobiological implications
    Year: 2022
    Authors: Acharya S, Saranyutanon S, Deshmukh SK, Khan MA, Singh S, Singh AP

 

  • Title: Ī²-Arrestin1 and GRK2 play permissive roles in Src-mediated endocytosis of Ī±4Ī²2 nicotinic acetylcholine receptor
    Year: 2021
    Authors: Acharya S, Kundu D, Kim KM

 

  • Title: Roles of the Functional Interaction between Brain Cholinergic and Dopaminergic Systems in the Pathogenesis and Treatment of Schizophrenia and Parkinson’s Disease
    Year: 2021
    Authors: Acharya S, Kim KM

 

  • Title: Clinicopathologic significance and race-specific prognostic association of MYB overexpression in ovarian cancer
    Year: 2021
    Authors: Miree, O., Srivastava, ā€¦Acharya S.et al.

 

  • Title: Metabotropic signaling cascade involved in Ī±4Ī²2 nicotinic acetylcholine receptor-mediated PKCĪ²II activation
    Year: 2020
    Authors: Acharya S, D. Kundu, H.J. Choi, and K.M. Kim

 

  • Title: Catalpol and Mannitol, Two Components of Rehmannia glutinosa, Exhibit Anticonvulsant Effects Probably via GABAA Receptor Regulation
    Year: 2019
    Authors: Acharya S, Kim M., Botanas C. J., Custodio R. J., Lee H. J., Sayson L. V., Kim H. J.

 

  • Title: Design, synthesis and in vitro activity of 1,4-disubstituted piperazines and piperidines as triple reuptake inhibitors
    Year: 2017
    Authors: Paudel S, Acharya S, Yoon G, Kim K.M., & Cheon S.H.

 

MARƍA JOSƉ RUIZ LEAL| Toxicologƭa | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. MARƍA JOSƉ RUIZ LEAL| Toxicologƭa | Best Researcher Award

Prof. Dr at University of Valencia,Ā  Spain

Dr. MarĆ­a JosĆ© Ruiz Leal, born on March 2, 1968, in Spain, is a distinguished Full Professor at the Universitat de ValĆØnciaā€™s Department of Preventive Medicine and Public Health. With a career spanning over two decades, she has significantly contributed to toxicology and food science, specializing in in vitro and in vivo studies related to pesticides and mycotoxins. Dr. Ruiz Leal has been part of multiple academic roles, growing from Associate Professor to Full Professor since 2018. She coordinates the Masterā€™s program in Food Quality and Safety at UV and leads the RiskTox research group. A European Registered Toxicologist since 2018, she is recognized for her extensive research portfolio and mentorship, supervising numerous doctoral theses and authoring over 130 scientific publications.

Profile

Orcid

Education šŸŽ“

Dr. MarĆ­a JosĆ© Ruiz Lealā€™s educational journey began at the Universitat de ValĆØncia (UV), where she earned her First Degree in Pharmacy in 1992, laying the foundation for her future in academic and applied toxicology. In 1997, she completed her PhD in Pharmacy, obtaining European certification, which equipped her with expertise in pharmaceutical sciences and toxicological research. Her education laid the groundwork for her focus on public health and safety, integrating in-depth studies on food sciences and toxicology. With continuous professional development, Dr. Ruiz Leal gained credentials as a European Registered Toxicologist (ERT) in 2018, underscoring her commitment to advancing toxicological standards and education.

Experience šŸ§‘ā€šŸ«

Dr. MarĆ­a JosĆ© Ruiz Lealā€™s extensive career at the Universitat de ValĆØncia (UV) commenced in 1998 with teaching and research roles, evolving from Assistant to Full Professor by 2018. Her work includes academic coordination of the Masterā€™s in Food Quality and Safety program since 2023. She has directed numerous research initiatives, leading eight significant projects and collaborating in about 20 regional, national, and international studies. Her focus lies in evaluating chemical impacts through in vitro cell cultures and in vivo methods, contributing to over 200 scientific congresses and publishing 131 papers in peer-reviewed journals, 90 of which are in Q1. Her experience is complemented by supervising 12 high-quality doctoral theses.

šŸ† Awards and Honors

Dr. MarĆ­a JosĆ© Ruiz Lealā€™s dedication and excellence in her field have been marked by numerous accolades. She boasts four sexenios of recognized research quality, the most recent in 2021, highlighting her sustained contributions to scientific production. Her doctoral theses supervision has been distinguished with quality mentions in the Food Science program. Her extensive publication record, with 131 articles and a significant h-index of 46, showcases the impact of her work, bolstered by 5,494 citations. As a European Registered Toxicologist since 2018, Dr. Ruiz Leal’s contributions to toxicology have been acknowledged within the scientific community and by her peers.

šŸ”¬ Research Focus

Dr. MarĆ­a JosĆ© Ruiz Lealā€™s research is rooted in toxicology and food safety, focusing on the impact of pesticides and mycotoxins using both in vitro and in vivo methodologies. Her work explores the cellular and systemic effects of contaminants, utilizing advanced cell culture techniques to assess toxicity and safety in food products. As the director of the RiskTox research group at UV, she leads innovative projects investigating chemical exposures and public health risks. Her contributions span international collaborations, addressing challenges in toxicological research and advancing knowledge in food science. Her expertise supports the development of safer food practices and regulatory standards.

Conclusion

Dr. Marƭa JosƩ Ruiz Leal is an exemplary researcher who has demonstrated exceptional academic and scientific leadership over her distinguished career. Her extensive publication record, contributions to pioneering toxicological research, and leadership within scientific organizations make her highly deserving of the Best Researcher Award. Moving forward, expanding into new, emerging research areas and increasing her public engagement would further elevate her impact in the field.

Publications šŸ“š

  • “Integrated Approach to Cyclopiazonic Acid Cytotoxicity Using In Vitro (2D and 3D Models) and In Silico Methods”
    • Authors: C. MartĆ­nez-Alonso, L. Izzo, Y. RodrĆ­guez-Carrasco, MJ. Ruiz
    • Year: 2024
    • Journal: Toxins 16, 473
    • Citations: 3

 

  • “Amitraz mechanisms of cytotoxicity in a characterized SH-SY5Y cells spheroid model”
    • Authors: F. Franco-Campos, M. FernĆ”ndez-FranzĆ³n, Y. RodrĆ­guez-Carrasco, MJ. Ruiz
    • Year: 2024
    • Journal: Toxicology 509, 153987
    • DOI: Link

 

  • “Identification of Biotransformation Products of T-2 Toxin in HepG2 Cells Using LC-Q-TOF MS”
    • Authors: M. Taroncher, V. Zingales, Y. RodrĆ­guez-Carrasco, MJ. Ruiz
    • Year: 2024
    • Journal: Foods 13 (10), 1501
    • DOI: Link

 

  • “Effect of Spirulina and Fish Processing By-Products Extracts on Citrinin-Induced Cytotoxicity in SH-SY5Y Cells”
    • Authors: FJ. MartĆ­-Quijal, JM. Castagnini, FJ. Barba, MJ. Ruiz
    • Year: 2024
    • Journal: Foods 13 (12), 1932
    • DOI: Link

 

  • “Comparative Study of Spheroids (3D) and Monolayer Cultures (2D) for the In Vitro Assessment of Cytotoxicity Induced by the Mycotoxins Sterigmatocystin, Ochratoxin A and Patulin”
    • Authors: V. Zingales, MR. Esposito, M. Quagliata, E. Cimetta, MJ. Ruiz
    • Year: 2024
    • Journal: Foods 13 (4), 564
    • DOI: Link

 

  • “Chlorpyrifos induces cytotoxicity via oxidative stress and mitochondrial dysfunction in HepG2 cells”
    • Authors: C. MontanarĆ­, F. Franco-Campos, M. Taroncher, Y. RodrĆ­guez-Carrasco, V. Zingales, MJ. Ruiz
    • Year: 2024
    • Journal: Food Chemistry and Toxicology 192, 114933
    • DOI: Link

 

  • “Using Microfluidic Hepatic Spheroid Cultures to Assess Liver Toxicity of T-2 Mycotoxin”
    • Authors: M. Taroncher, AM. Gonzalez-Suarez, K. Gwon, S. Romero, AD. Reyes-Figueroa, Y. RodrĆ­guez-Carrasco, MJ. Ruiz, G. Stybayeva, A. Revzin, JM. de Hoyos-Vega
    • Year: 2024
    • Journal: Cells

 

 

N T Pramathesh Mishra | Pharmacology | Young Scientist Award

Posted on by ScienceFather

Assoc Prof Dr. N T Pramathesh Mishra | Pharmacology| Best Scholar Award

Associate Professor at Hygia College of Pharmacy, India

As an accomplished Associate Professor in Pharmacology, I aim to contribute to innovative scientific research, advanced drug discovery, and training future healthcare professionals . With over a decade of experience and recognition, including awards like the Daniel Bovet Distinguished Young Scientist Award and Karma Veer Chakra Global Youth Fellowship , I am dedicated to advancing pharmacology and fostering collaborative research initiatives . My goal is to engage in cutting-edge research, impactful workshops, and inspire the next generation of scientists and healthcare providers

Publication

    1. Effect of COVID-19 Pandemic Lockdowns on Planned Cancer Surgery for 15 Tumour Types in 61 Countries
      Journal: The Lancet Oncology
      Year: 2021
      Citations: 256

     

    1. Global Impacts of Pre-and Post-COVID-19 Pandemic: Focus on Socio-Economic Consequences
      Journal: Sensors International
      Year: 2020
      Citations: 140

     

    1. Endophyte-Mediated Modulation of Defense-Related Genes and Systemic Resistance in Withania somnifera (L.) Dunal Under Alternaria alternata Stress
      Journal: Applied and Environmental Microbiology
      Year: 2018
      Citations: 77

     

    1. Molecular Mechanisms and Therapeutic Strategies for Levodopa-Induced Dyskinesia in Parkinsonā€™s Disease
      Journal: Frontiers in Pharmacology
      Year: 2022
      Citations: 30

     

    1. Supplementation of Trichoderma Improves the Alteration of Nutrient Allocation and Transporter Genes Expression in Rice Under Nutrient Deficiencies
      Journal: Plant Physiology and Biochemistry
      Year: 2019
      Citations: 23

     

    1. Clinicomycological Study of Dermatophytoses in Children Presenting at a Tertiary Care Center
      Journal: Indian Journal of Paediatric Dermatology
      Year: 2018
      Citations: 21

    Conclusion

    N T Pramathesh Mishra is a strong candidate for the Young Scientist Award due to his robust academic background, impactful research contributions, and recognition through prestigious awards. His diverse experience, innovative patents, and involvement in significant research projects reflect his potential as a leading young scientist. Addressing the areas for improvement, particularly in publication and broader collaboration, could further strengthen his candidacy and enhance his impact in the scientific community.

Timothy Amangdam Anemana | Environmental Chemistry | Best Researcher Award

Posted on by ScienceFather

Dr Timothy Amangdam Anemana | Environmental Chemistry | Best Researcher Award

Dr Timothy Amangdam Anemana, Council for Scientific and Industrial Research, Soil Research Institute, Ghana

Dr. Timothy Amangdam Anemana is an accomplished Environmental Chemist with a deep passion for soil and water remediation. Holding a Ph.D. in Environmental Science from Eƶtvƶs LorƔnd University, Hungary, he specializes in reducing arsenate and inorganic chromium mobility in soils. With a strong academic foundation and extensive experience in research and environmental consulting, Dr. Anemana has contributed significantly to the fields of biochar production, environmental risk assessment, and soil nutrient mapping. Currently serving as a Research Scientist at the CSIR-Soil Research Institute in Ghana, he leads projects aimed at developing sustainable agricultural practices and environmental conservation methods. Dr. Anemana is known for his dedication to advancing environmental science through innovative research, technical expertise, and community engagement.

Publication Profile

Google Scholar

Strengths for the Award

  • Extensive Research Background: Dr. Anemana holds a Ph.D. in Environmental Science, with a focus on Environmental Chemistry. His research spans critical areas such as soil remediation, biochar production, and environmental impact assessments. This demonstrates a solid foundation in both theoretical and applied environmental research.
  • Diverse Employment Experience: His roles as a Research Scientist, Environmental Chemist, and Ph.D. Research Fellow have equipped him with a broad skill set, including laboratory management, fieldwork, and the application of modern analytical techniques (e.g., ICP-MS, FTIR, LC-MS). His experience with the CSIR-Soil Research Institute and the Environmental Protection Agency in Ghana underlines his practical contributions to both academia and industry.
  • Publications and Academic Contributions: Dr. Anemana has published research in reputable journals, showcasing his ability to contribute original research to the scientific community. His work on biochar and soil nutrient mapping highlights his expertise in sustainable agricultural practices.
  • Mentorship and Teaching: His role as a lecturer and supervisor at the CSIR College of Science and Technology demonstrates his commitment to education and mentorship, further contributing to his suitability for the award.

Areas for Improvement

  • Broader Impact of Research: While Dr. Anemanaā€™s research is highly specialized, expanding the application and impact of his findings to address global environmental challenges could enhance his profile. A stronger emphasis on how his work influences policy, industry standards, or large-scale environmental solutions could be beneficial.
  • Increased Publication and Citation: Although he has published several papers, increasing the volume of high-impact publications and ensuring they are widely cited would strengthen his candidacy. Collaborations with international researchers could also broaden the scope and impact of his research.
  • Leadership in Large-Scale Projects: Taking on leadership roles in larger, multidisciplinary research projects could further demonstrate his ability to lead and innovate in the environmental sciences.

EducationĀ 

Dr. Timothy Amangdam Anemana has a diverse and rigorous academic background that laid the foundation for his expertise in Environmental Chemistry. He earned his Ph.D. in Environmental Science (with a major in Environmental Chemistry) from Eƶtvƶs LorĆ”nd University, Budapest, Hungary, in 2020, where he conducted groundbreaking research on reducing arsenate and inorganic trivalent chromium mobility in soils. Prior to this, he obtained an MSc. in Chemistry (Environmental Chemistry major) from Patrice Lumumba Peoplesā€™ Friendship University of Russia in 2013, focusing on the complex formation of azo derivatives with metal salts. He also holds a Diploma in Education from the University of Education, Winneba-Kumasi, and an Advanced Certificate in Energy Policy and Planning from Kwame Nkrumah University of Science and Technology. His academic journey began with a BSc. in Agriculture Technology from the University for Development Studies, Tamale, Ghana, where he investigated water and land use quality assessment.

ExperienceĀ 

Dr. Timothy Amangdam Anemana has a rich professional history in environmental research, consulting, and education. He currently serves as a Research Scientist at the CSIR-Soil Research Institute in Ghana, where he is involved in cutting-edge projects on soil nutrient mapping, biochar production, and environmental risk assessments. His previous role as an Environmental Chemist at the Environmental Protection Agency, Ghana, honed his skills in environmental impact assessments, biochar application for remediation, and air quality monitoring. Dr. Anemana’s experience also includes a Ph.D. Research Fellowship at Eƶtvƶs LorĆ”nd University, Hungary, where he contributed to advanced research on contaminated soils and innovative remediation techniques. Earlier in his career, he worked as a Postgraduate Research Assistant at Patrice Lumumba Peoplesā€™ Friendship University of Russia, focusing on laboratory instruction and environmental research. His extensive experience underscores his expertise in environmental chemistry and sustainable agricultural practices.

Awards and HonorsĀ 

Dr. Timothy Amangdam Anemana has been recognized for his outstanding contributions to environmental science and research. He graduated with a Ph.D. in Environmental Science from Eƶtvƶs LorƔnd University, Hungary, with the highest honor, summa cum laude. His work on the reduction of arsenate and inorganic trivalent chromium mobility in soils has been widely acclaimed. Dr. Anemana has also been acknowledged for his innovative research on biochar production and its application in soil and water remediation. Throughout his academic and professional journey, he has received numerous accolades for his dedication to environmental conservation and sustainable agricultural practices. His research publications have been featured in reputable international journals, and he continues to be a leading voice in environmental chemistry, contributing to the advancement of knowledge and practical solutions in this critical field.

Research Focus

Dr. Timothy Amangdam Anemana’s research is centered on the intersection of environmental chemistry and sustainable agricultural practices. His primary focus is on the development of innovative solutions for soil and water remediation, particularly the reduction of arsenate and inorganic trivalent chromium mobility in soils. He is deeply involved in the production and application of biochar and activated charcoal from biowaste materials, aiming to enhance soil fertility and mitigate environmental pollution. Dr. Anemana’s current projects at the CSIR-Soil Research Institute in Ghana include the development of an alternative triple super phosphate fertilizer from oyster shells, which are abundant in Ghana. His research also extends to environmental risk assessments, soil nutrient mapping, and the application of modern analytical instrumentation to solve complex environmental challenges. Through his work, Dr. Anemana seeks to contribute to sustainable development and environmental conservation on both local and global scales.

Publication Top Notes

šŸ“„ Optimization of lignite particle size for stabilization of trivalent chromium in soils | T. Anemana, et al. | Soil and Sediment Contamination: An International Journal 29(3), 272-291, 2020

šŸ§Ŗ Granular activated charcoal from peanut shell as a new candidate for stabilization of arsenic in soil | T. Anemana, et al. | Microchemical Journal 149, 104030, 2019

šŸŒ Simultaneous Determination of Heavy Metals in Competitive Aqueous Solutions and Contaminated Soil Systems | T. Anemana, et al. | Kalahari Journals, 2022

šŸ§¬ Experimental and theoretical investigations of complex formation of substituted phenylazo-derivatives of methylphloroglucinol | A.T. Amangdam, et al. | Journal of Advances in Chemistry 4(1), 2013

šŸŒ± Iodide- and electrochemical assisted removal of mercury by Cirsium arvense from gold tailings in the Amansie West District, Ghana | T.A. Anemana, et al. | International Journal of Phytoremediation, 2024

 

Conclusion

Dr. Timothy Amangdam Anemana is a strong candidate for the Research for Best Researcher Award, given his extensive experience in environmental chemistry, his contributions to soil and water remediation, and his role in mentoring the next generation of scientists. To enhance his candidacy, he could focus on increasing the global impact of his research and expanding his leadership in large-scale projects. With these enhancements, Dr. Anemana’s already impressive profile would be further solidified as a leading researcher in his field.

Daniele Florio | Pharmaceutical science | Young Scientist Award

Posted on by ScienceFather

Mr. Daniele Florio | Pharmaceutical science | Young Scientist Award

Daniele Florio is a dedicated researcher in pharmaceutical sciences, currently pursuing a Ph.D. at the University of Naples Federico II. His doctoral work focuses on integrated molecular approaches targeting mutated Nucleophosmin 1 in Acute Myeloid Leukemia, scheduled for completion in October 2024. Daniele brings extensive experience from his Marie Sklodowska-Curie secondment and voluntary internship, specializing in peptide synthesis, mass spectrometry, and spectroscopic techniques. With a strong publication record and active participation in international conferences, he contributes significantly to the fields of amyloid aggregation, chemical catalysis, and drug development, showcasing advanced skills in scientific research and analysis.

Profile

Scopus

šŸ‘Øā€šŸ«Professional Experience

Tutoring Activities (Grant Type B) 2023-2024, Naples, Italy, Department of Pharmacy, University of Naples Federico II, Provided supplementary teaching for Chemistry and Inorganic Chemistry courses for Pharmacy and CTF degree students. Ph.D. Candidate in Pharmaceutical Sciences (XXXVII Cycle) 2021 ā€“ Present, Naples, Italy, Department of Pharmacy, University of Naples Federico II, PhD Project: Integrated molecular approaches targeting mutated Nucleophosmin 1 in Acute Myeloid Leukemia., Scheduled PhD end: October 31, 2024. Secondee under Marie Skłodowska-Curie Research and Innovation Staff Exchange Action June 2022 ā€“ March 2023, Dublin, Ireland, Keladapharmachem, Participated in the GreenX4Drug (EU funded H2020 RISE project), focusing on developing novel asymmetric chemical catalysts for manufacturing high-value APIs and advanced intermediates.. Voluntary Internship Post-Degree 2018 ā€“ 2019, Naples, Italy, Department of Pharmacy, University of Naples Federico II, Designed, synthesized, and characterized peptides, peptidomimetics, and small molecules using solid-phase and solution methodologies. Utilized mass spectrometry (ESI) for identifying synthetic compounds and applied analytical and preparative methodologies (HPLC) for their purification and characterization. Conducted structural and functional characterization of biomolecules through spectroscopic techniques (CD, Fluorescence, SPR, UV-Vis). Supervisor: Prof. Daniela Marasco

šŸŽ“Education and Training

Biologist Board Examination February 7, 2022, University of Naples Federico II, Naples, Italy Masterā€™s Degree in Biological Science (Molecular Diagnostics Field) July 12, 2021, Naples, Italy Department of Pharmacy, University of Naples Federico II Experimental Thesis: “Protein fragments of Nucleophosmin 1 as models of amyloids”, Supervisor: Prof. Antonello Merlino, Co-Supervisor: Prof. Daniela Marasco,k Grade: 110/110. Bachelorā€™s Degree in Biological Science (Molecular Diagnostics Field) March 15, 2018, Naples, Italy Department of Pharmacy, University of Naples Federico II Experimental Thesis: “Amyloid-like aggregation of Nucleophosmin 1 regions related to Acute Myeloid Leukemia: spectroscopic studies” Supervisor: Prof. Daniela Marasco Grade: 106/110

šŸ“–Certifications

English TELSA C1, Grade B Language Certification ESAT, Malta Further & Higher Education Authority

Skills and Competencies

Organizational Skills

  • Efficient under pressure.
  • Adaptive to changes and new situations.
  • Strong independent work organization and goal achievement.

Job-related Skills

  • Solid-phase peptide synthesis and combinatorial peptide libraries using Fmoc/Boc chemistry.
  • Experience with various peptide synthesizers (BIOTAGE, Liberty Blue 2.0).
  • Proficient in analysis and purification using ESI mass spectrometry, HPLC, and flash purification systems.
  • Skilled in spectroscopic techniques (CD, Fluorescence, DLS, SPR, UV-Vis, FTIR, NMR).

Digital Skills

  • Proficient in Microsoft Office Suite.
  • Experienced with operating systems: MS-Windows, MacOS, LINUX.
  • Proficient in scientific data analysis software (GraphPad Prism).
  • Knowledgeable in databases (PubMed) and bibliographic management software (EndNote, Mendeley).
  • Proficient with video conferencing software (Teams, Skype, Zoom, Google Meet).
  • Excellent knowledge of major browsers (Edge, Chrome, Firefox, Safari, Opera).

šŸŒProjects

National Project Participation

  • BANDO-PRIN-2022. Research Project: Design, synthesis, and investigation of novel G-quadruplex aptamers against STAT3 and the interleukin-6 receptor (G4-APTASTAT).
  • Project Coordinator and Head of Research Unit: Prof. GALEONE Aldo

Bibliometric Parameters

  • H-index from Scopus: 11
  • Number of Publications: 24
  • Citations: 388

 

Publications Top Notes šŸ“

  • The effects of histidine substitution of aromatic residues on the amyloidogenic properties of the fragment 264ā€“277 of nucleophosmin 1
    • Authors: D. Florio, P. Luciano, C. Di Natale, D. Marasco
    • Journal: Bioorganic Chemistry
    • Volume: 147
    • Year: 2024
    • Pages: 107404

 

  • Could Targeting NPM1c+ Misfolding Be a Promising Strategy for Combating Acute Myeloid Leukemia?
    • Authors: D. Florio, D. Marasco
    • Journal: International Journal of Molecular Sciences
    • Volume: 25
    • Issue: 2
    • Year: 2024
    • Pages: 811

 

  • Modulation of hydrogel networks by metal ions
    • Authors: S. La Manna, D. Florio, C. Di Natale, D. Marasco
    • Journal: Journal of Peptide Science
    • Volume: 29
    • Issue: 8
    • Year: 2023
    • Article ID: e3474

 

  • Ruthenium complexes bearing glucosyl ligands are able to inhibit the amyloid aggregation of short histidine-peptides
    • Authors: D. Florio, S. La Manna, A. Annunziata, M. Monti, D. Marasco
    • Journal: Dalton Transactions
    • Volume: 52
    • Issue: 25
    • Year: 2023
    • Pages: 8549ā€“8557

 

  • Insights into Network of Hot Spots of Aggregation in Nucleophosmin 1
    • Authors: D. Florio, S. La Manna, C. Di Natale, A.M. Malfitano, D. Marasco
    • Journal: International Journal of Molecular Sciences
    • Volume: 23
    • Issue: 23
    • Year: 2022
    • Pages: 14704

 

  • Hydrogelation tunability of bioinspired short peptides
    • Authors: S. La Manna, D. Florio, V. Panzetta, C. Di Natale, D. Marasco
    • Journal: Soft Matter
    • Volume: 8
    • Year: 2022
    • Pages: 8